This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Acura Pharmaceuticals Inc
ACUR : NASDAQ : Health Care
$0.83 0.00 | 0.00%
Today's Range: 0.82 - 0.86
Avg. Daily Volume: 71,600
09/17/14 - 12:10 PM ET

PEER GROUP: Pharmaceuticals



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ACUR ACURA PHARMACEUTICALS INC 0.89 43.47 n/m 0.20 3800.00
IMMY IMPRIMIS PHARMACEUTICALS INC 7.86 71.76 n/m 0.67 13380.00
CBRX COLUMBIA LABORATORIES INC 6.05 65.17 31.84 29.04 3.48
ALXA ALEXZA PHARMACTCLS INC 2.93 50.90 n/m 7.13 -84.46
SKBI SKYSTAR BIO-PHARMACEUTICAL 5.59 46.93 4.40 46.69 38.72
NBY NOVABAY PHARMACEUTICALS INC 0.87 44.18 n/m 2.02 -69.51
TSPT TRANSCEPT PHARMACEUTICALS 2.10 40.24 n/m 1.34 -61.47
PRPH PROPHASE LABS INC 1.56 30.11 n/m 23.52 -1.91
BSPM BIOSTAR PHARMACEUTICALS INC 1.63 25.23 8.15 58.37 12.23
OCLS OCULUS INNOVATIVE SCIENCES 2.40 20.34 3.53 13.69 -7.35
TPI TIANYIN PHARMACEUTICAL CO 0.68 20.01 3.78 55.71 -18.78
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

ACUR Ind Avg S&P 500
n/m 41.16 19.81
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs